InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for August 2023. The filing states that on August 31, 2023, the Company issued a press release reporting financial results for the six months ended June 30, 2023.
Financial Metrics
The filing text provided does not include the attached press release or clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial data or describe material changes versus the prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or information regarding unusual items. These matters may be addressed in Exhibit 99.1, which is referenced but not included in the provided text.
Key Facts to Verify
- Obtain and review Exhibit 99.1, the August 31, 2023 financial-results press release.
- Verify reported results for the six months ended June 30, 2023, including revenue, profitability, cash flow, liquidity, and debt.
- Review management’s outlook, operating commentary, risk factors, and any non-GAAP measures in the attached press release.